Aligos Therapeutics, Inc. (ALGS) News
Track canonical SquawkNews coverage tagged to ALGS, Aligos Therapeutics, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 3 indexed stories across 3 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Aligos Therapeutics Doses First Participant
Aligos Therapeutics announces first participant dosed in Phase 1 study of ALG-170675
EQUITY | Aug 12, 2026, 08:07 PM UTC
L
ALGS - Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2026 Financial Results
ALGS - Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2026 Financial Results
EARNINGS | Aug 06, 2026, 12:01 PM UTC
L
ALGS - Aligos Therapeutics to Announce 2nd Quarter 2026 Financial Results on August 6, 2026
ALGS - Aligos Therapeutics to Announce 2nd Quarter 2026 Financial Results on August 6, 2026
EARNINGS | Jul 30, 2026, 12:00 PM UTC